These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9588557)

  • 21. Overexpressed WAF1/Cip1 renders glioblastoma cells resistant to chemotherapy agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin.
    Ruan S; Okcu MF; Ren JP; Chiao P; Andreeff M; Levin V; Zhang W
    Cancer Res; 1998 Apr; 58(7):1538-43. PubMed ID: 9537261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The 1p-encoded protein stathmin and resistance of malignant gliomas to nitrosoureas.
    Ngo TT; Peng T; Liang XJ; Akeju O; Pastorino S; Zhang W; Kotliarov Y; Zenklusen JC; Fine HA; Maric D; Wen PY; De Girolami U; Black PM; Wu WW; Shen RF; Jeffries NO; Kang DW; Park JK
    J Natl Cancer Inst; 2007 Apr; 99(8):639-52. PubMed ID: 17440165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of carbamoylation on cell survival and DNA repair in normal human embryo cells (IMR-90) treated with various 1-(2-chloroethyl)-1-nitrosoureas.
    Sariban E; Erickson LC; Kohn KW
    Cancer Res; 1984 Apr; 44(4):1352-7. PubMed ID: 6704956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitivity of CHO mutant cell lines with specific defects in nucleotide excision repair to different anti-cancer agents.
    Damia G; Imperatori L; Stefanini M; D'Incalci M
    Int J Cancer; 1996 Jun; 66(6):779-83. PubMed ID: 8647649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea.
    Liu L; Markowitz S; Gerson SL
    Cancer Res; 1996 Dec; 56(23):5375-9. PubMed ID: 8968088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular resistance to chloroethylnitrosoureas, nitrogen mustard, and cis-diamminedichloroplatinum(II) in human glial-derived cell lines.
    Aida T; Bodell WJ
    Cancer Res; 1987 Mar; 47(5):1361-6. PubMed ID: 3469016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cytotoxicity of a 2-chloroethylnitrosourea analog of sarcosinamide in the SK-MG-1 human glioma cell line as a possible indicator for transport.
    Skalski V; Feindel W; Panasci LC
    J Neurooncol; 1989 Jul; 7(2):189-93. PubMed ID: 2476532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea, a novel chloroethylnitrosourea analogue with enhanced antitumor activity against human glioma xenografts.
    Marcantonio D; Panasci LC; Hollingshead MG; Alley MC; Camalier RF; Sausville EA; Dykes DJ; Carter CA; Malspeis L
    Cancer Res; 1997 Sep; 57(18):3895-8. PubMed ID: 9307267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a 116 kDa protein able to bind 1,3-bis(2-chloroethyl)-1-nitrosourea-damaged DNA as poly(ADP-ribose) polymerase.
    Malapetsa A; Noë AJ; Poirier GG; Desnoyers S; Berger NA; Panasci LC
    Mutat Res; 1996 Jan; 362(1):41-50. PubMed ID: 8538647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
    Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
    Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Both extraneuronal monoamine transporter and O(6)-methylguanine-DNA methyltransferase expression influence the antitumor efficacy of 2-chloroethyl-3-sarcosinamide- 1-nitrosourea in human tumor xenografts.
    Chen ZP; Wang ZM; Carter CA; Alley MC; Mohr G; Panasci LC
    J Pharmacol Exp Ther; 2001 Mar; 296(3):712-5. PubMed ID: 11181897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA repair protein levels vis-à-vis anticancer drug resistance in the human tumor cell lines of the National Cancer Institute drug screening program.
    Xu Z; Chen ZP; Malapetsa A; Alaoui-Jamali M; Bergeron J; Monks A; Myers TG; Mohr G; Sausville EA; Scudiero DA; Aloyz R; Panasci LC
    Anticancer Drugs; 2002 Jun; 13(5):511-9. PubMed ID: 12045463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Over-representation of specific regions of chromosome 22 in cells from human glioma correlate with resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Hank NC; Shapiro JR; Scheck AC
    BMC Cancer; 2006 Jan; 6():2. PubMed ID: 16393339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anticancer drug induced sister chromatid exchange and correlation to cell survival in human brain tumor cells].
    Aida T; Bodell WJ
    No To Shinkei; 1987 Mar; 39(3):235-41. PubMed ID: 3472531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correction by the ERCC2 gene of UV sensitivity and repair deficiency phenotype in a subset of trichothiodystrophy cells.
    Mezzina M; Eveno E; Chevallier-Lagente O; Benoit A; Carreau M; Vermeulen W; Hoeijmakers JH; Stefanini M; Lehmann AR; Weber CA
    Carcinogenesis; 1994 Aug; 15(8):1493-8. PubMed ID: 8055625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transport of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in the human glioma cell line SK-MG-1 is mediated by an epinephrine-sensitive carrier system.
    Noë AJ; Malapetsa A; Panasci LC
    Mol Pharmacol; 1993 Jul; 44(1):204-9. PubMed ID: 8341272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenoviral transfer of antisenses or ribozyme to O6-methylguanine-DNA methyltransferase mRNA in brain-tumor model resistant to chloroethyl-nitrosourea.
    Manome Y; Yoshinaga H; Watanabe M; Ohno T
    Anticancer Res; 2002; 22(4):2029-36. PubMed ID: 12174880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas.
    Paz MF; Yaya-Tur R; Rojas-Marcos I; Reynes G; Pollan M; Aguirre-Cruz L; García-Lopez JL; Piquer J; Safont MJ; Balaña C; Sanchez-Cespedes M; García-Villanueva M; Arribas L; Esteller M
    Clin Cancer Res; 2004 Aug; 10(15):4933-8. PubMed ID: 15297393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant and nonmalignant brain tissues differ in their messenger RNA expression patterns for ERCC1 and ERCC2.
    Dabholkar MD; Berger MS; Vionnet JA; Egwuagu C; Silber JR; Yu JJ; Reed E
    Cancer Res; 1995 Mar; 55(6):1261-6. PubMed ID: 7882319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural and mutational analysis of the xeroderma pigmentosum group D (XPD) gene.
    Frederick GD; Amirkhan RH; Schultz RA; Friedberg EC
    Hum Mol Genet; 1994 Oct; 3(10):1783-8. PubMed ID: 7849702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.